Related Experiment Videos
Effects of oxotremorine after nigrostriatal lesions in rats
Abstract:
Bilateral injection of 6-hydroxy-dopamine (6-OH-DA) (8mug/4mul) into the substantia nigra causes a significant decrease of the dopamine content in the nucleus caudatus. The intraventricular application of 6-OH-DA (250 mug/10 mul) induces a considerable decrease of dopamine in the caudate nucleus as well as in the globus pallidus and in the medial septal region. Simultaneous changes in norepinephrine content are less spezific. It has to be assumed that there are dopaminergic nerve endings in the glubus pallidus not originating in the substantia nigra. Only after intraventricular applications of 6-OH-DA s short-term and reversible reduction of oxotremorin-induced tremor has been observed. Lesions of the nigrostriatal pathway cause an impairment of motility, probably elicited by rigidity and akinesia. These symptoms correlate better than the tremor to biochemical changes following nigro-striatal pathway lesions.
Insights
Bilateral injections of 6-hydroxy-dopamine (6-OH-DA) into the substantia nigra reduce dopamine levels in the caudate nucleus. Intraventricular 6-OH-DA also depletes dopamine in other brain regions, impacting motility.
Area of Science:
- Neuroscience
- Neurochemistry
Background:
- The substantia nigra plays a crucial role in motor control via dopaminergic pathways.
- Understanding dopamine distribution and function is essential for neurodegenerative disease research.
Purpose of the Study:
- To investigate the effects of 6-hydroxy-dopamine (6-OH-DA) on dopamine levels in various brain regions.
- To correlate biochemical changes with motor impairments.
Main Methods:
- Bilateral injections of 6-OH-DA into the substantia nigra.
- Intraventricular administration of 6-OH-DA.
- Measurement of dopamine and norepinephrine content in brain nuclei.
- Observation of motor behaviors, including tremor, rigidity, and akinesia.
Main Results:
- Bilateral substantia nigra 6-OH-DA injections significantly decreased dopamine in the caudate nucleus.
- Intraventricular 6-OH-DA reduced dopamine in the caudate nucleus, globus pallidus, and medial septal region.
- Norepinephrine level changes were less specific.
- Intraventricular 6-OH-DA caused a short-term, reversible reduction in oxotremorine-induced tremor.
- Nigrostriatal pathway lesions impaired motility, causing rigidity and akinesia.
Conclusions:
- The substantia nigra is a primary source of dopamine for the caudate nucleus.
- Dopaminergic nerve endings exist in the globus pallidus, potentially independent of the substantia nigra.
- Motor impairments like rigidity and akinesia correlate better with nigrostriatal pathway lesions than tremor reduction.